Desmopressin vs TB-500
Overview
Desmopressin is primarily a hormonal peptide, while TB-500 is used for healing & recovery.
This page compares Desmopressin and TB-500 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Desmopressin | TB-500 | |
|---|---|---|
| Category | Hormonal | Healing & Recovery |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) | 2-5 mg |
| Frequency | Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia) | weekly |
| Reported benefits | central diabetes insipidus management, primary nocturnal enuresis in children, nocturia due to nocturnal polyuria, perioperative hemostasis in mild hemophilia A, hemostasis in Type I von Willebrand disease, management of polyuria following head trauma or pituitary surgery | Tissue repair, improved flexibility, reduced inflammation, enhanced recovery, hair growth stimulation |
| Reported side effects | hyponatremia (boxed warning), headache, facial flushing, nausea, abdominal cramps, fluid retention, hypotension, reflex tachycardia, hypertension, tachyphylaxis with repeated dosing, rare anaphylaxis | Minimal side effects. Rare: headache, nausea, injection site reactions |
Key differences
Primary use. Desmopressin is categorised under Hormonal, while TB-500 falls under Healing & Recovery. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Desmopressin: FDA-approved. TB-500: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Desmopressin is typically dosed at 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) (Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia)). TB-500 is typically dosed at 2-5 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking Desmopressin and TB-500 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Desmopressin and TB-500?
- Desmopressin is primarily a hormonal peptide, while TB-500 is used for healing & recovery. Desmopressin is FDA-approved for one or more indications, whereas TB-500 is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Desmopressin used for?
- Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders.
- What is TB-500 used for?
- Tissue repair, flexibility, inflammation.
- Can you take Desmopressin and TB-500 together?
- Some users combine peptides within a single protocol, but stacking Desmopressin and TB-500 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Desmopressin or TB-500 FDA-approved?
- Desmopressin is FDA-approved for one or more indications. TB-500 is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Desmopressin — full monograph: mechanism, research, dosing & references
- TB-500 — full monograph: mechanism, research, dosing & references